A tumor-targeting black phosphorus-based nanoplatform for controlled chemo-photothermal therapy of breast cancer
Combination therapy with high efficacy and precision shows great potential in breast cancer treatment. Herein, we developed a multifunctional nanocarrier (NBP@mSiO<sub>2</sub>-PEG-cRGD) for tumor-targeting chemo-photothermal therapy of breast cancer in a controlled manner. The nanocarrier was constructed by enveloping nano-sized black phosphorus (NBP) within a mesoporous silica shell (mSiO<sub>2</sub>) modified with the tumor-targeting peptide c(Arg-Gly-Asp-dPhe-Cys) (cRGD). Due to the existence of pore channels within mSiO<sub>2</sub>, NBP@mSiO<sub>2</sub>-PEG-cRGD achieved high loading efficiency of indole-3-carbinol (I3C) molecules (NBP@mSiO<sub>2</sub>-PEG-cRGD/I3C), an anti-tumor agent derived from food. Mediated by cRGD/integrin αvβ3 interaction, NBP@mSiO<sub>2</sub>-PEG-cRGD/I3C reached breast tumors in a targeted manner. Once irradiated by the near-infrared laser, our nanocarrier exhibited superior photothermal conversion, which not only induced photothermal therapy but also facilitated the release of I3C from NBP@mSiO<sub>2</sub>-PEG-cRGD/I3C within tumor cells to inhibit the activation of proto-oncogenic phosphoinositide 3-kinase (PI3K)-AKT signaling pathway and drive chemotherapy. All these attributes contributed to a satisfactory therapeutic effect toward breast tumors, manifesting in significant inhibition of cell proliferation, promotion of cell apoptosis, and reduction of tumor micro-vessel formation, which led to the efficient inhibition of tumor growth. Collectively, the nanocarrier developed here provided useful insights into the development of multifunctional platforms to effectively combat cancer.
Authors
- Hao Wan (ORCID: https://orcid.org/0000-0002-9990-2359)
- Ying Zhang (ORCID: https://orcid.org/0000-0002-8299-3848)
- Li Zhang (ORCID: https://orcid.org/0000-0001-7700-0357)
- Yang Lin (ORCID: https://orcid.org/0000-0001-8066-7435)
- Xiaofen Wang (ORCID: https://orcid.org/0000-0003-0439-8477)
- Jing Liu (ORCID: https://orcid.org/0000-0002-9377-1626)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- Dalian Medical University (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- State Key Laboratory of Food Science and Technology (CN)
Publication Details
- Journal
- Materials Today Bio
- Published
- 2025-02-08
- DOI
- https://doi.org/10.1016/j.mtbio.2025.101563
- Citations
- 5
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 3.37
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province